Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACE | P12821 | 10/20 | 0.59 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.56 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10739004 | 1.00 | ACE (0.59) | ACEABCB11HDAC8POLB | |
| SCHEMBL9545015 | 0.90 | ACE (0.56) | ACEABCB11HDAC8 | |
| SCHEMBL27726228 | 0.90 | ACE (0.56) | ACEABCB11HDAC8 | |
| SCHEMBL27726229 | 0.90 | ACE (0.56) | ACEABCB11HDAC8 | |
| SCHEMBL9545013 | 0.90 | ACE (0.56) | ACEABCB11HDAC8 | |
| SCHEMBL10752343 | 0.90 | HDAC8 (0.50) | ACEABCB11HDAC8 | |
| SCHEMBL27705655 | 0.90 | HDAC8 (0.50) | ACEABCB11HDAC8 | |
| SCHEMBL27726218 | 0.89 | ACE (0.55) | ACEABCB11HDAC8POLB | |
| SCHEMBL27726215 | 0.89 | ACE (0.55) | ACEABCB11HDAC8POLB | |
| SCHEMBL27726225 | 0.87 | ACE (0.55) | ACEABCB11HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101200493-B | (3S)-N-(L-aminoacyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, preparation method and uses thereof | UNIV CAPITAL MEDICAL | 2011-11-09 | — | — | CN | disclosed |
| CN-101200493-A | (3S)-N-(L-aminoacyl)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, preparation method and uses thereof | UNIV CAPITAL MEDICAL SCIENCES (CN) | 2008-06-18 | — | — | CN | disclosed |